Ishita Drugs & Industries Ltd Share Price

₹76.00 0.00 (0.00%) BSE
as updated on 26-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:74.00
  • Day's High:76.00

  • 52 Week Low62.35
  • 52 Week High99.64

Ishita Drugs & Industries Ltd's key Fundamentals

Market Cap ₹23 Cr.
P/E Ratio 23.4
TTM EPS 3.3
P/B Ratio 2.02
ROE 8.04
Debt to Equity 0.36
Face Value 10
BVPS 37.6
3 Year Sales Growth 2.11%

Ishita Drugs & Industries Ltd's Share Price Returns

1 Day 0.00%
1 Week 0.60%
1 Month 7.20%
3 Months -6.90%
6 Months -9.70%
1 Years -14.90%
3 Years 44.50%
5 Years 126.20%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Ishita Drugs & Industries Ltd Shareholding Pattern

Promoters

(49.96%)

Institutions

(0.00%)

Non-Institutions

(50.04%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Ishita Drugs & Industries Ltd

Ishita drugs & industries limited (IDIL), an Ishita Group company  was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

IDIL is engaged in the manufacture of various active pharma ingredients (bulk actives and their salts), bulk drug intermediates, excipients and fine chemicals. It has a state-of-art manufacturing facility, in terms of chemical synthesis, quality control and environmental safety.

Ishita Group is a respected member of the Indian business community for more than 3 decades. The group's interests encompass manufacture of a large number of bulk actives and their salts, drug intermediates, fine chemicals, food additives, specialty/ performance chemicals, pharmaceutical formulations, healthcare products, dyes and dye intermediates, distribution of financial products and other businesses. The ishita group derives its key strengths from its strong ethical practices and moral values in business commitments.

The company’s manufacturing facility is located on main State Highway 17, barely 25 km from Ahmedabad city. The plant incorporates facilities that are the state-of-art in chemical synthesis, quality control and energy efficiency. The provision of several different utility systems and equipments covering a large number of unit operations make the plant truly multi-purpose. This imparts the flexibility to alter the product mix in tune with the changing market needs or the needs of the customers for customized products.

The plant is equipped with various kinds of equipment to carry out varied kinds of reactions - ss vessels, glass lined ss reactors (glrs), ss centrifuges, rubber lined centrifuges, condensers, fluid bed dryers, ribbon blender, commuting mill, leaf filters, vibrator separators, multi mill etc. The plant also have various utilities suitable for different processes - oil heating, steam heating, ammonia chilling, brine chilling, compressed air, vacuum systems etc.

Product range of the company includes:

The current product list of Ishita includes APIs and intermediates

APIs

Antibiotics

  • Chloramphenicol bp/usp
  • Chloramphenicol palmitate bp/usp

Fluoro quinolones

  • Norfloxacin ip/usp/bp
  • Enrofloxacin base vet

Sulpha drugs

  • Sulfacetamide plain bp/usp
  • Sulphacetamide sodium (drc)
  • Sulfanilamide

Vitamins

  • Nicotinamide usp (inj.) / cosmetics grade
  • Nicotinic acid bp/usp

Anthelmintics

  • Piperazine hydrate
  • Piperazine citrate / adipate / phosphate

Iodides & citrates (salts)

  • Pot.iodide bp
  • Sod.iodide bp
  • Methyl iodide bp
  • Pot.citrate bp/usp
  • Sod.citrate bp/usp
  • Sod.acid citrate bp
  • Sodium chloride bp (pyrogen free)
  • Potassium chloride bp (pyrogen free)

Excipients

  • Maize starch bp
  • Sod.starch glycolate usp
  • Pumojel (sod.starch glycolate)

Other chemicals

  • Methyl nicotinate
  • Pyrazinamide
  • Salicylanilide
  • Para bromo toluene 99.5%
  • Pyridine hydrobromide
  • Potassium phthalimide
  • Nicotinic acid hydrazide

Intermediaries

  • 4-sulfonamido phenyl hydrazine hcl (celecoxib intermediate)
  • 4-chloro phenyl hydrazine hydrochloride
  • Q-acid and n2 ester (norfloxacin intermediates)
  • Tri methyl sulphonoxium iodide
  • 5 cyano phthalide
  • 7-amino - 3 phenyl coumarin
  • 2-hydroxy methyl 3,5 dimethyl 4-methoxy pyridine (omeprazole int.)
  • Hexa methyl disilazane
  • 5-chloromethopabate
  • Diacetyl sulfanilamide
  • L-alanine benzylester p-toluene sulfonate salt
  • 4 (chloroacetyl) n-methyl sulfonamide
  • Indole - 2 - carboxylic acid
  • Ethyl benzoyl acrylate
  • 4, 4' - dimethyl benzil
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 74.00
  • Day's High: 76.00

  • 52 Week Low62.35
  • 52 Week High99.64

Ishita Drugs & Industries Ltd's key Fundamentals

Market Cap ₹23 Cr.
P/E Ratio 23.4
TTM EPS 3.3
P/B Ratio 2.02
ROE 8.04
Debt to Equity 0.36
Face Value 10
BVPS 37.6
3 Year Sales Growth 2.11%

Ishita Drugs & Industries Ltd's Share Price Returns

1 Day 0.00%
1 Week 0.60%
1 Month 7.20%
3 Months -6.90%
6 Months -9.70%
1 Years -14.90%
3 Years 44.50%
5 Years 126.20%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×